ATE276268T1 - Upar-imitierende peptide - Google Patents

Upar-imitierende peptide

Info

Publication number
ATE276268T1
ATE276268T1 AT98916982T AT98916982T ATE276268T1 AT E276268 T1 ATE276268 T1 AT E276268T1 AT 98916982 T AT98916982 T AT 98916982T AT 98916982 T AT98916982 T AT 98916982T AT E276268 T1 ATE276268 T1 AT E276268T1
Authority
AT
Austria
Prior art keywords
peptides
upar
imimicating
useful
diseases
Prior art date
Application number
AT98916982T
Other languages
English (en)
Inventor
Francesco Blasi
Francesca Fazioli
Massimo Resnati
Sidenius Nicolai
Original Assignee
San Raffaele Centro Fond
Univ Degli Studi Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Raffaele Centro Fond, Univ Degli Studi Milano filed Critical San Raffaele Centro Fond
Application granted granted Critical
Publication of ATE276268T1 publication Critical patent/ATE276268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98916982T 1997-03-20 1998-03-18 Upar-imitierende peptide ATE276268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4111297P 1997-03-20 1997-03-20
PCT/EP1998/001547 WO1998042733A1 (en) 1997-03-20 1998-03-18 uPAR MIMICKING PEPTIDE

Publications (1)

Publication Number Publication Date
ATE276268T1 true ATE276268T1 (de) 2004-10-15

Family

ID=21914807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98916982T ATE276268T1 (de) 1997-03-20 1998-03-18 Upar-imitierende peptide

Country Status (9)

Country Link
US (1) US6462170B1 (de)
EP (1) EP0970106B1 (de)
AT (1) ATE276268T1 (de)
AU (1) AU7036398A (de)
CA (1) CA2283637C (de)
DE (1) DE69826255T2 (de)
DK (1) DK0970106T3 (de)
ES (1) ES2224378T3 (de)
WO (1) WO1998042733A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129332A (en) * 1999-04-05 2006-12-10 Hadasit Med Res Service suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
EP1365797B1 (de) * 2001-01-25 2007-05-02 Fondazione Centro San Raffaele Del Monte Tabor Antikörper zur modulierung der upa/upar interaktion und deren verwendungen
EP2189469B1 (de) * 2004-11-18 2015-09-16 The Board Of Trustees Of The University Of Illinois Multicistronische siRNA-Konstrukte zur Hemmung von Tumoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1290267C (en) * 1985-04-15 1991-10-08 Lorin K. Johnson Human anti-inflammatory phospholipase inhibitor protein
WO1994028014A2 (en) * 1993-05-28 1994-12-08 Chiron Corporation Peptide inhibitors of urokinase receptor activity
WO1995007106A1 (en) * 1993-09-10 1995-03-16 The Regents Of The University Of California A method for identifying mutagenic agents using sperm from transgenic mice

Also Published As

Publication number Publication date
US6462170B1 (en) 2002-10-08
ES2224378T3 (es) 2005-03-01
DE69826255T2 (de) 2005-01-27
DE69826255D1 (de) 2004-10-21
WO1998042733A1 (en) 1998-10-01
AU7036398A (en) 1998-10-20
CA2283637A1 (en) 1998-10-01
CA2283637C (en) 2007-11-13
EP0970106A1 (de) 2000-01-12
DK0970106T3 (da) 2005-01-10
EP0970106B1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
EP1019010A4 (de) Apolipoprotein-a-i-agonisten und ihre anwendung zum behandeln von dyslipidämischer erkrankung
EP0998569A4 (de) Polynukleotid kodierend für ein polypeptid mit heparanase-aktivität und dessen expression in transduzierten zellen
EP2258383A3 (de) Von der Telomerase abgeleitete antigene Peptide
NZ508381A (en) Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5)
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
ATE397062T1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
NO954722D0 (no) Peptid inhibitorer med urokinase reseptoraktivitet
NZ515678A (en) Human GIL-19/AE289 proteins and polynucleotides encoding same
DK1086225T3 (da) Humant tumorafledt polypeptidhormon phosphatonin
DE3885313D1 (de) Peptide mit Laminin-Wirksamkeit.
FI953093A0 (fi) Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä
MY104909A (en) Peptide compounds.
DE69826255D1 (de) uPAR-IMITIERENDE PEPTIDE
RU97103147A (ru) Днк-последовательности, кодирующие человеческие протеины тх и ту, родственные конвергирующему интерлейкин-1-бета ферменту
TR199902866T2 (xx) Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler.
DK0938329T3 (da) Immunogen TLP sammensætning
MY127669A (en) Polypeptide hormone phosphatonin
BR0008917A (pt) Compostos
BG105682A (en) Bone stimulating factor
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
DE3869939D1 (de) Biologisch wirksame peptide.
FR2722209B1 (fr) Recepteur opioide kappa humain, acides nucleiques et utilisations
IL115825A0 (en) Therapeutic protein
DE69420044D1 (de) Blutregulierende peptide
ATE305478T1 (de) Topoisomerase-ii inhibitoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0970106

Country of ref document: EP

REN Ceased due to non-payment of the annual fee